Caris Life Sciences (CAI) Inventory (2024 - 2026)

Caris Life Sciences' Inventory history runs 3 years deep, the most recent figure standing at $76.3 million for Q1 2026.

• On a quarterly basis, Inventory changed N/A year-over-year to $76.3 million in Q1 2026; TTM through Mar 2026 was $76.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $63.6 million, up 60.78% from the prior year.
• Inventory advanced to $76.3 million in Q1 2026 per CAI's latest filing, from $63.6 million in the prior quarter.
• Across five years, Inventory topped out at $76.3 million in Q1 2026 and bottomed at $39.6 million in Q4 2024.
• The 3-year median for Inventory is $49.3 million (2025), against an average of $53.9 million.
• Biggest YoY gain for Inventory was 60.78% in 2025; the steepest drop was 60.78% in 2025.
• Year by year, Inventory stood at $39.6 million in 2024, then jumped by 60.78% to $63.6 million in 2025, then climbed by 19.9% to $76.3 million in 2026.
• Per Business Quant, the three latest CAI Inventory figures stand at $76.3 million (Q1 2026), $63.6 million (Q4 2025), and $49.3 million (Q3 2025).